AstraZeneca Spies Success For Antibody To Prevent COVID-19 Infection In Vulnerable

Could Be First With Pre-Exposure Authorization

 
• By Andrew McConaghie
  
AstraZeneca
AstraZeneca's antibody combination, if authorized, will be fourth to market, but could prevent infection in vulnerable populations in whom vaccines are not fully effective, or in the unvaccinated.

More from Business

More from Scrip